APAC Heart Failure Gap Report
28 March 2023
KEY TAKEAWAYS
- Continued research is needed to address many gaps prevalent in the management of Heart Failure such as going beyond traditional tools for HF risk prediction in high risk patients.
- There is a need for high value methods for the biomarker use in optimization of HF therapy.
- Advanced role of precision medicine such as genetics, personalized and individualized factors for the medical management of HF patients.
Dr Jack Tan shares some of the salient findings from the APAC HF gap report project and the highlights of the consensus statement developed.
Disclaimer: The platforms may include third-party content (including data and information) and that Roche will not be responsible for third-party materials, including their accuracy, completeness and validity.
